Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| CNNArginineMe: A CNN structure for training models for predicting arginine methylation sites based on the One-Hot encoding of peptide sequence. | Front Genet | 2022 | 36324513 | PubTator, text mining | PubMed |
| Epigenetics in glaucoma: a link between histone methylation and neurodegeneration | J Clin Invest | 2022 | 36317630 | PubTator, text mining | PubMed |
| The kinesin motor KIF1C is a putative transporter of the exon junction complex in neuronal cells. | RNA | 2022 | 36316088 | PubTator, text mining | PubMed |
| Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma. | World J Clin Cases | 2022 | 36312469 | PubTator, text mining | PubMed |
| Identification of energy metabolism-related biomarkers for risk prediction of heart failure patients using random forest algorithm. | Front Cardiovasc Med | 2022 | 36304554 | PubTator, text mining | PubMed |
| Emerging role of lncRNAs in osteoarthritis: An updated review. | Front Immunol | 2022 | 36304464 | PubTator, text mining | PubMed |
| Tumor Progression, Microenvironments, and Therapeutics. | Life (Basel) | 2022 | 36295034 | PubTator, text mining | PubMed |
| PRMT7 Inhibitor SGC8158 Enhances Doxorubicin-Induced DNA Damage and Its Cytotoxicity. | Int J Mol Sci | 2022 | 36293180 | PubTator, text mining | PubMed |
| Alternative Splicing in Human Physiology and Disease. | Genes (Basel) | 2022 | 36292705 | PubTator, text mining | PubMed |
| The role of melatonin in the development of postmenopausal osteoporosis. | Front Pharmacol | 2022 | 36278157 | PubTator, text mining | PubMed |
| UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. | Oncogene | 2022 | 36273042 | PubTator, text mining | PubMed |
| Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers. | Front Oncol | 2022 | 36263200 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir. | Sci Transl Med | 2022 | 36260688 | PubTator, text mining | PubMed |
| Global profiling of arginine dimethylation in regulating protein phase separation by a steric effect-based chemical-enrichment method. | Proc Natl Acad Sci U S A | 2022 | 36256816 | PubTator, text mining | PubMed |
| The role of hepatocyte nuclear factor 4α (HNF4α) in tumorigenesis. | Front Oncol | 2022 | 36249028 | PubTator, text mining | PubMed |
| PRMT1 is an important factor for medulloblastoma cell proliferation and survival. | Biochem Biophys Rep | 2022 | 36237442 | PubTator, text mining | PubMed |
| Relationship between protein arginine methyltransferase and cardiovascular disease (Review). | Biomed Rep | 2022 | 36237286 | PubTator, text mining | PubMed |
| Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy. | Molecules | 2022 | 36235174 | PubTator, text mining | PubMed |
| A Screening of Epigenetic Therapeutic Targets for Non-Small Cell Lung Cancer Reveals PADI4 and KDM6B as Promising Candidates. | Int J Mol Sci | 2022 | 36233212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=30